VGXI: News
VGXI to Attend Alliance for Regenerative Medicine Annual Meeting on the Mesa
Conroe, Texas – VGXI, Inc., a leading provider of plasmid DNA manufacturing and development[…]
Read More
VGXI accepted as a Member of the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI, accepted as a Member of the US Government’s Rapid Response Partnership Vehicle (RRPV)
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc., a leading contract developer and manufacturer (CDMO) specializing in nucleic acid[…]
Read More
VGXI’s Expanded Manufacturing Capacity Addresses Plasmid DNA Supply Chain Challenges
Plasmid DNA (pDNA) is an essential part of the supply chain for advanced therapies and[…]
Read More
Stephanie Burke Named as VGXI’s New Chief Accounting Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Stephanie Burke as its new[…]
Read More
VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]
Read More
VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility
With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]
Read More
VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility
Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening[…]
Read More
